Medicine guide

EMTRICITABINE/TENOFOVIR DISOPROXIL ZENTIVA

As listed in the register: EMTRICITABINE/TENOFOVIR DISOPROXIL ZENTIVA 200 mg/245 mg, comprimé pelliculé

200 mg + 291,50 mg · comprimé pelliculé

  • Prescription only
Made by
ZENTIVA (REPUBLIQUE TCHEQUE)

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Details

Made byZENTIVA (REPUBLIQUE TCHEQUE)
Active substanceEmtricitabine + Phosphate De Ténofovir Disoproxil
Strength200 mg + 291,50 mg
Formcomprimé pelliculé
Routeorale
Dispensing (as stated by the register)liste I
MarketedNo — authorised but not currently marketed, according to the register
Authorisation procedureProcédure centralisée
EU numberEU/1/16/1148
Name in the registerEMTRICITABINE/TENOFOVIR DISOPROXIL ZENTIVA 200 mg/245 mg, comprimé pelliculé
Packs1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimé(s)
CIS66010949
CIP133400930076880

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.